That is essential, because the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and be efficient. To put it simply, we need to understand how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (melania trump). Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. This was a breakthrough nearly nobody discovered. But it's going to have profound ramifications for curing disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be lots of financial investment chances in this space, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (brownstone research). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it pulled back perhaps significantly before going higher - melania trump. I've been covering bitcoin for a long period of time now. One of the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were primarily informing readers. However that's not the huge concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown investor prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many excellent private companies on the brink of hitting the public markets And I've been dealing with a brand-new method for you to invest even prior to these companies go public.
This opportunity has been developing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to schedule your spot totally free.
Emma Walsh here, managing editor of the Diary. Regular Journal readers know that tech isn't our normal beat (jeff brown 1 biotech). And when it concerns tech investing, we leave it to the professionals. Fortunately, we have several such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing specialists we understand (brownstone research stock). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These patterns are experiencing rapid development and creating extraordinary opportunities for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown investment prediction. But regardless of what lots of readers might believe, this is a pattern that's just beginning. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown top biotech 2020). Losing 2 months of manufacturing and sales really impacts the number of 5G devices are sold in the fiscal year. When you think about all of that, selling 250 million systems is amazing. More importantly, the hold-ups triggered by the pandemic created a lot of bottled-up need. And that need is now going to be pressed into 2021. In reality, I predict that more than 500 million 5G devices will be delivered in 2021 - jeff brown prediction. Which's not my only 5G forecast When I have actually talked about 5G in the past, I have actually explained its three different stages.
In Phase 2, 5G gadgets go on sale. 5G phones and other products start to reach customers. And in Phase Three, 5G services start to be provided (jeff brown stock predictions 2021). That's when we begin to see applications operating on 5G networks. Believe of things like massive multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Phase Three by this summer season. This begins something of a virtuous cycle: Many people do not actually appreciate the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In fact, 5G is going to open up a suite of extraordinary applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment opportunities going forward will be huge. Stepping far from 5G, the next crucial technology I predict in 2021 is CRISPR hereditary editing. CRISPR stands for "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it is among the most exciting advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software application.
The program can crash or not function properly. CRISPR uses a comparable concept but with our hereditary code. "Typos" in our genome can lead to illness. CRISPR can remedy these "typos." For years, CRISPR was primarily a specific niche innovation that wasn't well understood. And during that time, there were really just three companies running in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this innovation just works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering extraordinary returns. This entire market is effectively a greenfield chance.
There's space for lots of business to exist in this area. jeff brown biotech stocks. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or three more hereditary modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things occurring at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can accurately forecast the folding of a protein based exclusively on its amino acid sequence with 92. 4% precision. That is very important due to the fact that the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been a trial-and-error procedure. Now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to produce drugs that do what they're designed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however a number of drug therapies produced using this technology. This was among those developments that nearly no one saw. But it's going to have extensive ramifications for treating disease. And, of course, there will be a lot of financial investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe considerably before going greater. I have actually been covering bitcoin for a long time now. Among the very first research reports I ever released was on bitcoin - jeff brown prediction for 2021. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However nobody is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. jeff brown genome sequencing. Mass, Mutual is a 150-year-old institution. So believe about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the details depends on date since February 2021, but we might not independently confirm this claim. Provided Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like capability to pick winning technology stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an excellent point of view on the market. He's always on the hunt for new chances, and he shares a number of his finest picks in the Near Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding track record as a stock-picker, and he successfully forecasted some of the greatest financial occasions of the previous twenty years. Although he does not appear to release his picks to the public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it ideal every time, however Jeff Brown's precise predictions have made him legions of dedicated followers. That says a lot about his ability. The Near Future Report is released by Brownstone Research study, a popular financial research study publisher. Brownstone Research study uses numerous research services with a large range of specializations - biotech stock.
The business is also associated with Bonner & Partners, another well-respected research publisher - jeff brown stock picks 2021. On its website, Brownstone says its objective is to supply retail financiers with professional-grade research study: "For too long, the finest financial investment research study has not been offered to private financiers. It has actually been generally booked for financial investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown biotech stock pick for 2020. The mission of Brownstone Research study is to make that kind of exclusive research study offered to any financiers seeking to acquire an edge in the marketplaces. The goal is simple to deliver special and profitable financial investment research found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also acts as the firm's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout most of America. If you understand even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. tech predictions. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown believes S.A.V. social media. could be "the greatest pattern of the 2020s, and he's not alone. Inspect out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding 2 innovative technologies: expert system and electrical cars and trucks. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing except the vehicle market's Holy Grail. As you know, electric cars and self-driving cars and truck stocks have been big this year, however the Wall Street machine has been huge on hype without much tangible result. In spite of a drastic boost in competitors over the previous few years, Brown still believes Musk has the best possibility of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. means Shared Autonomous Car, and it might be the future of transportation. Generally, this innovation would allow you to rent your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You merely get out of the cars and truck and press a button on an app that tells the automobile to "sign up with the fleet." Next thing you know, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a large piece of the earnings. It sounds crazy, however it could be closed than you think.